Fortis Healthcare Limited has formally announced its schedule for upcoming investor and analyst meetings through an official communication dated April 22, 2026. The healthcare company has informed both the National Stock Exchange of India and BSE Limited about the planned interactions with the investment community, providing detailed information about the comprehensive engagement program.

Official Communication and Regulatory Compliance

The announcement comes through official letter reference FHL/SEC/2026-27, signed by Company Secretary and Compliance Officer Satyendra Chauhan. The communication has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring proper disclosure to both major stock exchanges where the company's shares are listed.

Meeting Details and Schedule

The healthcare company has organized a comprehensive investor engagement program spanning two days in Mumbai. The meetings are structured as a non-deal roadshow organized by JM Financial, providing investors and analysts with insights into the company's operations and the broader healthcare industry landscape.

Meeting Focus and Information Disclosure

The investor meetings are designed to discuss general business updates and developments within the healthcare industry in which Fortis Healthcare operates. The company has specifically emphasized that no Unpublished Price Sensitive Information (UPSI) will be shared or discussed during the investor meetings, ensuring adherence to regulatory guidelines governing investor interactions and information disclosure.

The company has indicated that the schedule and timings remain subject to changes due to potential exigencies on the part of either investors or the company. The two-day format allows for extensive engagement with the investment community, providing opportunities for both individual discussions and group presentations while accommodating various investor preferences and requirements.

Major healthcare providers are reportedly facing scrutiny over their billing practices for basic medical items, according to a recent CNBC Aawaz report. The allegations center on overcharging patients for essential medical supplies including syringes and gloves.

Healthcare Providers Under Scrutiny

The report specifically mentions Fortis Healthcare and Apollo Hospital as healthcare providers allegedly involved in overcharging practices. These allegations focus on basic medical consumables that are routinely used in healthcare facilities.

Items Under Question

The overcharging allegations specifically relate to:

• Medical syringes
• Medical gloves
• Other basic medical items

Industry Implications

Such allegations, if substantiated, could raise broader questions about pricing transparency in the private healthcare sector. The focus on basic medical items like syringes and gloves highlights concerns about billing practices for routine medical consumables that patients typically encounter during hospital visits and treatments.

The CNBC Aawaz report brings attention to pricing practices that may affect patient costs for essential medical supplies across healthcare facilities.